Advertisements


We are Sorry, This Page doesn't Exist


Johnson & Johnson Stock Rises on Earnings Beat

JNJ's strong second-quarter performance was driven by its drug business......»»

Category: topSource: moneycentralJul 17th, 2018

Evercore says FDA tentatively approves generic of another top 10 Valeant drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Mid-Afternoon Market Update: Dow Rises 150 Points; Biogen Shares Climb On Positive Alzheimer"s Drug Trial

Toward the end of trading Friday, the Dow traded up 0.62 percent to 24,506.75 while the NASDAQ climbed 1.26 percent to 7,681.80. The S&P also rose, gaining 0.91 percent to 2,761.60. read more.....»»

Category: blogSource: benzingaJul 6th, 2018

Valeant is back on to its old drug-pricing ways

Valeant is using two techniques to raise prices on one of its best-selling drugs: a larger package and a higher per-milligram price......»»

Category: topSource: marketwatchJun 29th, 2018

23 Stocks Moving In Thursday"s Pre-Market Session

Gainers Teligent, Inc. (NASDAQ: TLGT) shares rose 21.4 percent to $3.97 in pre-market trading following the FDA approval of abbreviated new drug application for Diflorasone Diacetate Ointment 0.05%. read more.....»»

Category: blogSource: benzingaJun 14th, 2018

‘Female Viagra’ Founder Is Back as CEO After Valeant Gave the Billion-Dollar Drug Back for Free

Cindy Eckert is back — and she has some big plans. Cindy Eckert (previously Cindy Whitehead) is back at the helm of Sprout .....»»

Category: europeSource: fortuneJun 11th, 2018

Morning Movers: Twitter Sinks on Offering, Valeant Gains on Upgrade

The Dow Looks set for a higher open this morning, as the Nasdaq looks set to trade a new all-time high. Twitter sinks on a convertible-debt offering, Valeant rises on a Barclays upgrade, and Signet jumps on earnings......»»

Category: blogSource: barronsJun 6th, 2018

CRISPR Faces FDA Clinical Hold

CRISPR Therapeutics shares saw a significant drop on Thursday morning after an announcement that the FDA placed a clinical hold on the Investigational New Drug Application (IND) for CTX001 for the........»»

Category: blogSource: 247wallstMay 31st, 2018

FDA Confirms September Action Date for Teva"s Migraine Drug

Teva (TEVA) confirms that FDA has extended the goal date of the Biologics License Application (BLA) for fremanezumab to September from mid-June. Teva Pharmaceutical Industries Ltd. TEVA confirmed that FDA has extended t.....»»

Category: smallbizSource: nytMay 24th, 2018

Nipah virus toll in Kerala rises to 10; will Hep C drug provide a cure?

Neighbouring Tamil Nadu issues travel warning; medical team from AIIMS arrives on state's request.....»»

Category: topSource: business-standardMay 22nd, 2018

Glenmark Pharma submits application for new drug Ryaltris with USFDA

Ryaltris is for treatment of seasonal allergic rhinitis (SAR) in patients 12 years of age and older.....»»

Category: topSource: business-standardMay 22nd, 2018

Nabriva to file a new drug application with US FDA in Q4

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 21st, 2018

Declining sale of key drug weighs on Sun Pharma, stock down 7% in 2 days

Sales of acne drug Absorica were down 26 per cent on a sequential basis in the March quarter.....»»

Category: topSource: business-standardMay 14th, 2018

Wall Street rises with healthcare rally after Trump"s speech

(Reuters) - The S&P 500 rose on Friday, helped by healthcare stocks after President Donald Trump blasted high drug prices but avoided taking aggressive measures to cut them......»»

Category: topSource: reutersMay 11th, 2018

Trump Today: Trump Today: President lays out drug price plan, talks mileage standards with auto makers

President Donald Trump on Friday laid out his plan to curb prescription drug price rises and talked to automotive executives about loosening mileage standards......»»

Category: topSource: marketwatchMay 11th, 2018

Trump Today: Trump Today: President lays out drug price plan, talks mileage standards with automakers

President Donald Trump on Friday laid out his plan to curb prescription drug price rises and talked to automotive executives about loosening mileage standards......»»

Category: topSource: marketwatchMay 11th, 2018

Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses

Catalyst reported in-line loss in Q1. The company resubmitted a new drug application for its lead candidate Firdapse and expects FDA to accept the NDA in Q2. Catalyst Pharmaceuticals, Inc. CPRX reported a loss of 6 cents per share in the .....»»

Category: smallbizSource: nytMay 10th, 2018

MediciNova opens investigational new drug application for MN166 in Glioblastoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2018

AcelRx resubmits new drug application for DSUVIA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2018

Brainstorm Health: Takeda Scores Shire, Valeant Name Change, Walmart Opioids Plan

Brainstorm Health Daily: May 8, 2018 Good afternoon, readers! This is Sy. Embattled drug maker Valeant finally got a bit of g.....»»

Category: europeSource: fortuneMay 8th, 2018